NYSE:BMY   Bristol-Myers Squibb Company
This stock has been stuck in the $75 range all year has fallen after therapy drug flops. Oversold and good for a bounce back to $70
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。